期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Medicine and Data. 2026; 10: (1) ; 75-77 ; DOI: 10.12208/j.ijmd.20260017.

Clinical treatment observation of bacterial pneumonia in the elderly
老年人细菌性肺炎临床治疗观察

作者: 陈倩 *

南京市祖堂山精神病院 江苏南京

*通讯作者: 陈倩,单位:南京市祖堂山精神病院 江苏南京; ;

发布时间: 2026-03-31 总浏览量: 67

摘要

目的 分析老年人细菌性肺炎临床治疗观察。方法 选择我院在2022年7月份至2025年6月份收治的28例患者进行研究,随机平衡法分成对照组和实验组,每组14例患者,对照组提供头孢唑肟;实验组莫西沙星,对比两组患者临床症状改善时间和不良反应发生率。结果 实验组患者临床症状改善时间短于对照组,实验组患者不良反应发生率低于对照组(均P<0.05)。结论 对老年细菌性肺炎患者提供莫西沙星治疗,安全性更佳,可以满足患者治疗需求,促进患者恢复,值得提倡。

关键词: 老年人;细菌性肺炎;临床治疗;观察

Abstract

Objective To analyze the clinical treatment observation of bacterial pneumonia in the elderly.
Methods Twenty-eight patients admitted to our hospital from July 2022 to June 2025 were selected for the study. They were randomly divided into the control group and the experimental group by the balanced method, with 14 patients in each group. The control group was provided with cefazoloxime; In the experimental group, moxifloxacin was used to compare the improvement time of clinical symptoms between the two groups of patients. Incidence of adverse reactions.
Results The improvement time of clinical symptoms in the experimental group was shorter than that in the control group, p<0.05, and the incidence of adverse reactions in the experimental group was lower, p<0.05.
Conclusion   Providing moxifloxacin treatment for elderly patients with bacterial pneumonia is safer, can meet the treatment needs of patients, promote their recovery, and is worthy of promotion.

Key words: Elderly people; Bacterial pneumonia; Clinical treatment; Observation

参考文献 References

[1] 陈雅倩,姬长存,杨洪卫.头孢哌酮舒巴坦联合阿奇霉素治疗老年细菌感染性重症肺炎的临床效果分析[J].中国社区医师,2024,40(34):16-18.

[2] 黄富城.注射用头孢曲松联合宣肺止嗽合剂治疗细菌性肺炎的临床疗效观察[J].现代诊断与治疗,2024,35(11): 1644-1646.

[3] 于淑倩,闫永霞,刘会,孙万飞.注射用头孢噻肟钠联合蒲地蓝口服液治疗老年细菌性肺部感染患者的临床疗效分析[J].中华保健医学杂志,2024,26(3):374-376.

[4] 刘疆,邱思鸿,周莹,李娜,姚晓蝶,罗季.奥马环素与莫西沙星治疗社区获得细菌性肺炎的有效性和安全性Meta分析[J].中国抗生素杂志,2025,50(8):973-980.

[5] 朱琳,杨文静,尤立蕊.头孢曲松钠联合阿奇霉素与莫西沙星治疗老年社区获得性肺炎的临床效果及安全性比较[J].临床合理用药,2025,18(12):69-72.

[6] 吴智,张伟良,吴小丽,罗嘉敏.哌拉西林/他唑巴坦治疗老年人重症社区获得性细菌性肺炎的临床研究[J].深圳中西医结合杂志,2024,34(17):110-113.

[7] 李贺,王星凯,边竞.宣肺败毒颗粒联合哌拉西林舒巴坦治疗老年人重症肺炎的临床疗效[J].深圳中西医结合杂志, 2023,33(15):33-36.

[8] 侯雪凯,张悦,唐肃,张雪瑞,孙聪聪.头孢哌酮钠舒巴坦钠与头孢唑肟联合经鼻高流量正压通气治疗重症肺炎患儿的效果比较[J].中国民康医学,2025,37(15):156-158,162.

[9] 于淑倩,闫永霞,刘会,孙万飞.注射用头孢噻肟钠联合蒲地蓝口服液治疗老年细菌性肺部感染患者的临床疗效分析[J].中华保健医学杂志,2024,26(3):374-376.

[10] 宋效英.头孢唑肟钠联合盐酸氨溴索治疗老年人下呼吸道感染的效果探究[J].首都食品与医药,2025,32(14):47-49.

引用本文

陈倩, 老年人细菌性肺炎临床治疗观察[J]. 国际医学与数据杂志, 2026; 10: (1) : 75-77.